Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hochuekkito plus pulmonary rehabilitation for apathy in COPD
jRCTs061180042Completed
- Sponsor
- Tsumura & Co.
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of buzhong yiqi in chronic obstructive pulmonary disease (COPD) and apathy (2 arms), sponsored by Tsumura & Co. Primary endpoints: Apathy scale score and Number of steps. Started Apr 2018; status: completed.
02
Drugs
buzhong yiqi
03
Conditions
chronic obstructive pulmonary disease (COPD)apathy
Beyond the preview
Go deeper on jRCTs061180042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs061180042.